We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Horizontal Centrifuge Developed for Hospital and Reference Laboratories

By Labmedica staff writers
Posted on 08 Jan 2008
A manufacturer and marketer of automated in-vitro diagnostic (IVD) urinalysis systems and medical devices have developed a high speed, horizontal centrifuge for use in hospital and reference laboratories.

Called the StatSpin Express 4, the new centrifuge addresses the increasing demand facing hospital laboratories for more efficient sample processing and rapid turnaround of patient results. More...
It employs a unique horizontal rotor for separating gel tubes in just minutes and replaces larger and slower, batch centrifuges by reducing sample preparation time and streamlining laboratory workflow.

The centrifuge will enable laboratories to meet their "lean” initiatives, a rapidly growing trend in the clinical chemistry laboratory. Lean processing eliminates non-value added steps in a process such as batching and waiting for samples to be processed. With the new centrifuge, laboratories can "go lean”; reducing labor while improving workflow and turnaround time. The unit is designed to handle the demands of central chemistry laboratories where hundreds of runs per day are required.

Manufactured by Iris International's Sampling Processing Division (Westwood, MA, USA), the centrifuge will facilitate the company's entry into the high volume chemistry test market and enable further application expansion in blood and body fluids.

"Samples can be processed as they arrive in the laboratory; no need for batching, no unproductive time waiting for the completion of a long centrifugation cycle. With the Express 4, workflow is streamlined and samples move quickly to the analyzer resulting in faster turnaround of patient results,” said Robert Mello, president of Iris Sample Processing. "In just three minutes, the Express 4 can produce serum or plasma equal to that spun for 10 minutes or more in conventional horizontal centrifuges.”


Related Links:
Iris International's Sampling Processing Division

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Nasopharyngeal Applicator
CalgiSwab 5.5" Sterile Mini-tip Calcium Alginate Nasopharyngeal Swab w/Aluminum HDLE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.